Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,569,700 | 2,489,700 | 2,655,500 | 2,646,700 | 2,887,100 |
| Depreciation Amortization | 851,000 | 908,800 | 740,700 | 637,200 | 600,800 |
| Income taxes - deferred | 30,700 | 59,100 | 127,500 | 74,300 | 101,800 |
| Accounts receivable | -1,899,700 | -418,300 | 189,900 | -401,800 | 109,700 |
| Accounts payable and accrued liabilities | 1,240,600 | -345,800 | -53,700 | 978,000 | -330,700 |
| Other Working Capital | -160,700 | -766,900 | -671,200 | 62,100 | -2,244,500 |
| Other Operating Activity | 737,700 | 1,125,700 | -244,100 | -622,100 | 292,500 |
| Operating Cash Flow | $3,369,300 | $3,052,300 | $2,744,600 | $3,374,400 | $1,416,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -545,600 | -405,100 | N/A | 28,900 | -504,800 |
| PPE Investments | -626,600 | -607,300 | -544,500 | -515,800 | -450,600 |
| Net Acquisitions | 740,000 | N/A | -4,597,000 | -600,000 | -300 |
| Purchase Of Investment | -10,731,100 | -14,776,300 | -15,576,900 | -12,381,700 | -11,009,500 |
| Sale Of Investment | 10,255,900 | 13,662,800 | 15,915,600 | 12,654,300 | 10,769,200 |
| Other Investing Activity | -67,500 | -108,500 | 251,200 | -127,700 | -75,500 |
| Investing Cash Flow | $-974,900 | $-2,234,400 | $-4,551,600 | $-942,000 | $-1,271,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,768,600 | 1,514,900 | 316,600 | 335,300 | 576,900 |
| Debt Issued | 2,320,800 | 1,058,300 | 6,239,900 | 1,561,000 | 924,100 |
| Debt Repayment | -1,730,100 | -1,801,900 | -1,251,300 | -705,100 | -481,700 |
| Common Stock Issued | 301,300 | 524,700 | 110,800 | 245,000 | 143,600 |
| Common Stock Repurchased | -2,998,800 | -1,620,100 | -2,496,800 | -3,039,800 | -4,360,300 |
| Dividend Paid | -480,700 | -448,000 | -367,100 | -357,800 | N/A |
| Other Financing Activity | -2,003,600 | -945,700 | -463,200 | -57,800 | 28,100 |
| Financing Cash Flow | $-1,822,500 | $-1,717,800 | $2,088,900 | $-2,019,200 | $-3,169,300 |
| Exchange Rate Effect | -7,100 | 2,200 | 1,100 | -400 | -3,200 |
| Beginning Cash Position | 1,586,900 | 2,484,600 | 2,201,600 | 1,788,800 | 4,816,100 |
| End Cash Position | 2,151,700 | 1,586,900 | 2,484,600 | 2,201,600 | 1,788,800 |
| Net Cash Flow | $564,800 | $-897,700 | $283,000 | $412,800 | $-3,027,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,369,300 | 3,052,300 | 2,744,600 | 3,374,400 | 1,416,700 |
| Capital Expenditure | -714,600 | -646,500 | -544,900 | -519,500 | -451,400 |
| Free Cash Flow | 2,654,700 | 2,405,800 | 2,199,700 | 2,854,900 | 965,300 |